시장보고서
상품코드
1813548

mRNA 합성 및 제조 시장 분석과 예측(-2034년) : 유형, 제품, 서비스, 기술, 용도, 프로세스, 최종사용자, 컴포넌트, 스테이지

mRNA Synthesis and Manufacturing Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, Process, End User, Component, Stage

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 318 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

mRNA 합성·제조 시장은 2024년 14억 달러에서 2034년에는 82억 달러로 확대하며, 약 19.3%의 CAGR로 성장할 것으로 예측됩니다. mRNA 합성 및 제조 시장에는 치료 및 백신용 메신저 RNA 생산이 포함됩니다. 이 시장은 mRNA 기반 솔루션의 신속한 개발 및 확장성을 가능하게 하는 생명공학 기술의 발전에 힘입어 성장하고 있습니다. 주요 분야는 합성 기술, 정제 공정, 유효성과 안전성을 보장하기 위한 품질관리 등이 있습니다. 맞춤형 의료와 감염병 대응 강화가 시장 성장을 촉진하고 있으며, 연구와 인프라에 대한 투자가 활발히 이루어지고 있습니다.

mRNA 합성 및 제조 시장은 생명공학 기술의 발전과 맞춤형 의료에 대한 수요 증가로 인해 강력한 성장세를 보이고 있습니다. 이 시장에서는 효율적이고 확장 가능한 생산 방식의 필요성으로 인해 합성 분야가 주도하고 있습니다. 변형 뉴클레오티드의 합성은 mRNA의 안정성과 번역 효율을 높이는 역할을 하므로 특히 주목받고 있습니다. 제조 분야에서는 전문적인 서비스와 전문 지식을 제공할 수 있는 수탁제조기관(CMO)이 각광을 받고 있습니다. 백신 개발 부문은 mRNA 백신의 성공에 힘입어 감염병 대응을 위한 mRNA 백신의 성공에 힘입어 최고 수준의 실적을 달성하고 있습니다. 치료제는 특히 종양학 및 희귀질환에서 표적치료제로의 전환을 반영하여 두 번째로 높은 성과를 거두었습니다. 지질 나노입자 전달 시스템의 혁신도 mRNA 기반 치료제의 전달과 효능을 향상시켜 시장 확대에 기여하고 있습니다.

시장 세분화
유형 시험관내 전사 mRNA, 수식 mRNA, 비수식 mRNA, 자기 증폭 mRNA
제품 mRNA 컨스트럭트, mRNA 백신, mRNA 치료제, mRNA 전달 시스템
서비스 커스텀 mRNA 합성, mRNA 최적화, 분석 서비스, 품질관리, 규제 지원
기술 무세포 시스템, 효소 합성, 화학 합성, 마이크로플루이딕스 시스템
용도 감염증, 암치료, 유전자 질환, 심혈관질환, 희귀질환
프로세스 업스트림 공정, 다운스트림 공정, 제제화, Fill and Finish
최종사용자 제약회사, 바이오테크놀러지 기업, 연구기관, 제조 수탁 기관
컴포넌트 뉴클레오티드, 효소, 완충액, 시약
스테이지 전임상, 임상, 상업

시장 현황

mRNA 합성 및 제조 시장은 시장 점유율, 가격 전략, 제품 혁신에 있으며, 역동적인 변화를 겪고 있습니다. 기존 기업은 시장 침투력을 높이기 위해 경쟁력 있는 가격 책정에 집중하는 반면, 신규 진출기업은 새로운 비즈니스 기회를 잡기 위해 혁신적인 제품을 출시하고 있습니다. 이 시장에는 치료 용도에 중점을 둔 제품 파이프라인이 풍부합니다. 북미는 기술 발전과 R&D 투자 증가에 힘입어 시장을 주도하고 있습니다. 한편, 아시아태평양은 전략적 제휴와 인프라 확대로 인해 탄력을 받고 있습니다. 경쟁 구도의 특징은 Moderna, BioNTech, CureVac 등 주요 기업이 전략적 제휴와 기술력으로 업계의 벤치마크를 설정하고 있다는 점입니다. 북미와 유럽의 규제 프레임워크는 매우 중요하며, 시장 역학 및 컴플라이언스 표준에 영향을 미치고 있습니다. 시장은 합성생물학 및 맞춤의료의 발전에 힘입어 성장할 태세를 갖추고 있습니다. 그러나 규제 장벽과 높은 제조 비용 등의 과제는 여전히 남아있습니다. 그럼에도 불구하고 진행 중인 기술 혁신과 전략적 파트너십은 이해관계자들에게 유리한 기회를 제공합니다.

주요 동향과 촉진요인:

mRNA 합성 및 제조 시장은 몇 가지 주요 동향과 촉진요인으로 인해 강력한 성장을 달성하고 있습니다. mRNA 기반 백신 및 치료제에 대한 수요 증가는 COVID-19 백신의 성공에 힘입은 주요 촉진제입니다. 이러한 수요는 생산 효율성과 확장성을 높이기 위한 첨단 제조 기술에 대한 투자에 박차를 가하고 있습니다. 주목할 만한 동향은 제조 공정의 자동화 및 디지털화로의 전환입니다. 이러한 발전은 제조 비용을 절감하고 정확도를 향상시켰습니다. 시장은 또한 연구개발을 가속화하기 위해 생명공학 기업과 학계와의 협력이 활발히 이루어지고 있습니다. 자금 지원과 유리한 규제 프레임워크를 통한 정부의 지원은 시장 확대를 더욱 촉진하고 있습니다. 또한 맞춤형 의료가 강조되고 있는 가운데, mRNA 기술은 맞춤형 치료법 개발에 중요한 역할을 하고 있습니다. 이러한 개별화 솔루션에 대한 관심은 mRNA 합성의 기술 혁신을 촉진하고 있습니다. 이러한 동향과 촉진요인이 진화하는 헬스케어 니즈와 기술 발전과 맞물리면서 시장은 지속적인 성장을 이룰 것으로 보입니다.

억제요인과 과제:

mRNA 합성 및 제조 시장은 몇 가지 중요한 억제요인과 문제에 직면해 있습니다. 주요 과제는 첨단 기술과 전문 지식을 필요로 하는 제조 공정의 복잡성입니다. 이러한 복잡성은 종종 제조 비용의 상승으로 이어져 mRNA 기반 제품의 확장성과 경제성을 제한하고 있습니다. 규제 장벽도 큰 과제입니다. 엄격한 규제 상황을 극복하기 위해서는 많은 시간과 자원이 필요하며, 제품 개발 및 시장 개발이 늦어지고 있습니다. 또한 원료 공급망은 끊어지기 쉬워 mRNA 치료제의 적시 생산 및 유통에 영향을 미칩니다. 지적재산권 문제도 점점 더 복잡해지고 있습니다. 시장 경쟁의 특성상 특허 분쟁이 빈번하게 발생하여 기술 혁신과 공동연구를 저해하고 있습니다. 또한 mRNA 제품의 콜드체인 물류가 필요하므로 운영비용이 상승하고, 인프라가 부족한 지역에서는 유통이 제한될 수 있습니다. 마지막으로 mRNA 기술에 대한 대중의 인식이나 잘못된 정보는 시장 수용과 수요에 영향을 미칠 수 있습니다.

주요 기업

BioNTech, Moderna, CureVac, Translate Bio, Arcturus Therapeutics, Sangamo Therapeutics, eTheRNA Immunotherapies, Ethris, TriLink BioTechnologies, Aldevron, Ginkgo Bioworks, Senti Biosciences, Nutcracker Therapeutics, GreenLight Biosciences, Acuitas Therapeutics

목차

제1장 mRNA 합성·제조 시장 개요

  • 조사 목적
  • mRNA 합성·제조 시장의 정의와 조사 범위
  • 리포트의 제한 사항
  • 조사 대상 연도와 통화
  • 조사 방법

제2장 개요

제3장 시장에 관한 주요 인사이트

제4장 mRNA 합성·제조 시장 전망

  • mRNA 합성·제조 시장 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 mRNA 합성·제조 시장 전략

  • 모시장 분석
  • 수급 분석
  • 소비자 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 mRNA 합성·제조 시장 규모

  • mRNA 합성·제조 시장 규모 : 금액별
  • mRNA 합성·제조 시장 규모 : 수량별

제7장 mRNA 합성·제조 시장 : 유형별

  • 시장 개요
  • 시험관내 전사 mRNA
  • 수식 mRNA
  • 비수식 mRNA
  • 자기 증폭형 mRNA
  • 기타

제8장 mRNA 합성·제조 시장 : 제품별

  • 시장 개요
  • mRNA 컨스트럭트
  • mRNA 백신
  • mRNA 치료제
  • mRNA 딜리버리 시스템
  • 기타

제9장 mRNA 합성·제조 시장 : 서비스별

  • 시장 개요
  • 커스텀 mRNA 합성
  • mRNA 최적화
  • 분석 서비스
  • 품질관리
  • 규제 지원
  • 기타

제10장 mRNA 합성·제조 시장 : 기술별

  • 시장 개요
  • 무세포 시스템
  • 효소 합성
  • 화학 합성
  • 마이크로플루이딕스 시스템
  • 기타

제11장 mRNA 합성·제조 시장 : 용도별

  • 시장 개요
  • 감염증
  • 암치료
  • 유전자 질환
  • 심혈관질환
  • 희귀질환
  • 기타

제12장 mRNA 합성·제조 시장 : 프로세스별

  • 시장 개요
  • 업스트림 공정
  • 다운스트림 공정
  • 제제화
  • Fill-finish
  • 기타

제13장 mRNA 합성·제조 시장 : 최종사용자별

  • 시장 개요
  • 제약 기업
  • 바이오테크놀러지 기업
  • 연구기관
  • 제조 수탁 기관
  • 기타

제14장 mRNA 합성·제조 시장 : 컴포넌트별

  • 시장 개요
  • 뉴클레오티드
  • 효소
  • 완충액
  • 시약
  • 기타

제15장 mRNA 합성·제조 시장 : 스테이지별

  • 시장 개요
  • 전임상
  • 임상
  • 상업
  • 기타

제16장 mRNA 합성·제조 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트
    • 남아프리카공화국
    • 기타 중동 및 아프리카

제17장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략 벤치마킹

제18장 기업 개요

  • BioNTech
  • Moderna
  • CureVac
  • Translate Bio
  • Arcturus Therapeutics
  • Sangamo Therapeutics
  • eTheRNA Immunotherapies
  • Ethris
  • TriLink BioTechnologies
  • Aldevron
  • Ginkgo Bioworks
  • Senti Biosciences
  • Nutcracker Therapeutics
  • GreenLight Biosciences
  • Acuitas Therapeutics
KSA 25.09.30

mRNA Synthesis and Manufacturing Market is anticipated to expand from $1.4 billion in 2024 to $8.2 billion by 2034, growing at a CAGR of approximately 19.3%. The mRNA Synthesis and Manufacturing Market encompasses the production of messenger RNA for therapeutic and vaccine applications. This market is driven by advancements in biotechnology, enabling rapid development and scalability of mRNA-based solutions. Key areas include synthesis technologies, purification processes, and quality control to ensure efficacy and safety. The rise in personalized medicine and infectious disease response is propelling market growth, with significant investments in research and infrastructure.

The mRNA Synthesis and Manufacturing Market is experiencing robust growth, spurred by advancements in biotechnology and increasing demand for personalized medicine. Within the market, the synthesis segment is leading, driven by the need for efficient and scalable production methods. The synthesis of modified nucleotides is particularly noteworthy, given its role in enhancing mRNA stability and translation efficiency. The manufacturing segment is not far behind, with contract manufacturing organizations (CMOs) gaining prominence due to their ability to offer specialized services and expertise. The vaccine development sub-segment stands out as a top performer, propelled by the success of mRNA vaccines in combating infectious diseases. Therapeutics, especially in oncology and rare diseases, represent the second highest performing sub-segment, reflecting a shift towards targeted treatments. Innovations in lipid nanoparticle delivery systems are also contributing to the market's expansion, as they improve the delivery and efficacy of mRNA-based therapies.

Market Segmentation
TypeIn vitro Transcription mRNA, Modified mRNA, Unmodified mRNA, Self-amplifying mRNA
ProductmRNA Constructs, mRNA Vaccines, mRNA Therapeutics, mRNA Delivery Systems
ServicesCustom mRNA Synthesis, mRNA Optimization, Analytical Services, Quality Control, Regulatory Support
TechnologyCell-free Systems, Enzymatic Synthesis, Chemical Synthesis, Microfluidic Systems
ApplicationInfectious Diseases, Cancer Treatment, Genetic Disorders, Cardiovascular Diseases, Rare Diseases
ProcessUpstream Processing, Downstream Processing, Formulation, Fill and Finish
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations
ComponentNucleotides, Enzymes, Buffers, Reagents
StagePreclinical, Clinical, Commercial

Market Snapshot:

The mRNA Synthesis and Manufacturing Market is experiencing dynamic shifts in market share, pricing strategies, and product innovations. Established companies are focusing on competitive pricing to enhance market penetration, while new entrants are launching innovative products to capture emerging opportunities. The market is witnessing a robust pipeline of products, with a strong emphasis on therapeutic applications. North America dominates the landscape, driven by technological advancements and increased R&D investments. Meanwhile, the Asia-Pacific region is gaining momentum, fueled by strategic collaborations and expanding infrastructure. The competitive landscape is characterized by key players such as Moderna, BioNTech, and CureVac, who are setting industry benchmarks through strategic alliances and technological prowess. Regulatory frameworks in North America and Europe are pivotal, influencing market dynamics and compliance standards. The market is poised for growth, driven by advancements in synthetic biology and personalized medicine. However, challenges like regulatory hurdles and high production costs persist. Nonetheless, the ongoing innovation and strategic partnerships present lucrative opportunities for stakeholders.

Geographical Overview:

The mRNA synthesis and manufacturing market is witnessing robust growth across several regions, each presenting unique opportunities. North America is at the forefront, propelled by significant advancements in biotechnology and substantial investments in research and development. The presence of key industry players and a supportive regulatory framework further enhances the market's potential. Europe follows closely, with a strong focus on innovation and sustainable healthcare solutions. Government initiatives and funding for biopharmaceutical research are catalyzing market expansion. The region's commitment to cutting-edge medical research is fostering a conducive environment for mRNA technologies. In the Asia Pacific, the market is expanding rapidly, driven by technological advancements and increasing healthcare demands. Countries like China and India are emerging as pivotal growth pockets due to their vast population bases and growing investments in biotechnology. Latin America and the Middle East & Africa are also showing promising potential, with rising awareness and investments in mRNA technologies fueling market growth.

Key Trends and Drivers:

The mRNA synthesis and manufacturing market is experiencing robust growth due to several key trends and drivers. The increasing demand for mRNA-based vaccines and therapeutics is a primary driver, fueled by the success of COVID-19 vaccines. This demand is spurring investments in advanced manufacturing technologies to enhance production efficiency and scalability. A notable trend is the shift towards automated and digitalized manufacturing processes. These advancements are reducing production costs and improving precision. The market is also witnessing increased collaboration between biotech companies and academic institutions to accelerate research and development efforts. Government support through funding and favorable regulatory frameworks is further propelling market expansion. Moreover, there is a growing emphasis on personalized medicine, where mRNA technology plays a crucial role in developing tailored treatments. This focus on personalized solutions is driving innovation in mRNA synthesis. The market is poised for continued growth as these trends and drivers align with evolving healthcare needs and technological advancements.

Restraints and Challenges:

The mRNA Synthesis and Manufacturing Market faces several significant restraints and challenges. A primary challenge is the complexity of manufacturing processes, which requires advanced technology and specialized expertise. This complexity often leads to high production costs, limiting the scalability and affordability of mRNA-based products. Regulatory hurdles also pose a significant challenge. Navigating the stringent regulatory landscape requires substantial time and resources, delaying product development and market entry. Furthermore, the supply chain for raw materials is vulnerable to disruptions, impacting the timely production and distribution of mRNA therapeutics. Intellectual property issues add another layer of complexity. The competitive nature of the market leads to frequent patent disputes, hindering innovation and collaboration. Additionally, the need for cold chain logistics for mRNA products increases operational costs and limits distribution in regions with inadequate infrastructure. Lastly, public perception and misinformation about mRNA technology can affect market acceptance and demand.

Key Players:

BioNTech, Moderna, CureVac, Translate Bio, Arcturus Therapeutics, Sangamo Therapeutics, eTheRNA Immunotherapies, Ethris, TriLink BioTechnologies, Aldevron, Ginkgo Bioworks, Senti Biosciences, Nutcracker Therapeutics, GreenLight Biosciences, Acuitas Therapeutics

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: mRNA Synthesis and Manufacturing Market Overview

  • 1.1 Objectives of the Study
  • 1.2 mRNA Synthesis and Manufacturing Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by Process
  • 2.9 Key Highlights of the Market, by End User
  • 2.10 Key Highlights of the Market, by Component
  • 2.11 Key Highlights of the Market, by Stage
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by Process
  • 3.8 Market Attractiveness Analysis, by End User
  • 3.9 Market Attractiveness Analysis, by Component
  • 3.10 Market Attractiveness Analysis, by Stage
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: mRNA Synthesis and Manufacturing Market Outlook

  • 4.1 mRNA Synthesis and Manufacturing Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: mRNA Synthesis and Manufacturing Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: mRNA Synthesis and Manufacturing Market Size

  • 6.1 mRNA Synthesis and Manufacturing Market Size, by Value
  • 6.2 mRNA Synthesis and Manufacturing Market Size, by Volume

7: mRNA Synthesis and Manufacturing Market, by Type

  • 7.1 Market Overview
  • 7.2 In vitro Transcription mRNA
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Modified mRNA
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Unmodified mRNA
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Self-amplifying mRNA
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Others
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region

8: mRNA Synthesis and Manufacturing Market, by Product

  • 8.1 Market Overview
  • 8.2 mRNA Constructs
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 mRNA Vaccines
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 mRNA Therapeutics
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 mRNA Delivery Systems
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: mRNA Synthesis and Manufacturing Market, by Services

  • 9.1 Market Overview
  • 9.2 Custom mRNA Synthesis
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 mRNA Optimization
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Analytical Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Quality Control
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Regulatory Support
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Others
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region

10: mRNA Synthesis and Manufacturing Market, by Technology

  • 10.1 Market Overview
  • 10.2 Cell-free Systems
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Enzymatic Synthesis
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Chemical Synthesis
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Microfluidic Systems
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: mRNA Synthesis and Manufacturing Market, by Application

  • 11.1 Market Overview
  • 11.2 Infectious Diseases
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Cancer Treatment
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Genetic Disorders
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Cardiovascular Diseases
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Rare Diseases
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Others
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region

12: mRNA Synthesis and Manufacturing Market, by Process

  • 12.1 Market Overview
  • 12.2 Upstream Processing
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Downstream Processing
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Formulation
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Fill and Finish
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: mRNA Synthesis and Manufacturing Market, by End User

  • 13.1 Market Overview
  • 13.2 Pharmaceutical Companies
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Biotechnology Companies
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Research Institutes
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Contract Manufacturing Organizations
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Others
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region

14: mRNA Synthesis and Manufacturing Market, by Component

  • 14.1 Market Overview
  • 14.2 Nucleotides
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Enzymes
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Buffers
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Reagents
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Others
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region

15: mRNA Synthesis and Manufacturing Market, by Stage

  • 15.1 Market Overview
  • 15.2 Preclinical
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Clinical
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Commercial
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: mRNA Synthesis and Manufacturing Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Application
    • 16.2.7 North America Market Size and Forecast, by Process
    • 16.2.8 North America Market Size and Forecast, by End User
    • 16.2.9 North America Market Size and Forecast, by Component
    • 16.2.10 North America Market Size and Forecast, by Stage
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Application
      • 16.2.9.6 United States Market Size and Forecast, by Process
      • 16.2.9.7 United States Market Size and Forecast, by End User
      • 16.2.9.8 United States Market Size and Forecast, by Component
      • 16.2.9.9 United States Market Size and Forecast, by Stage
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Application
      • 16.2.10.6 Canada Market Size and Forecast, by Process
      • 16.2.10.7 Canada Market Size and Forecast, by End User
      • 16.2.10.8 Canada Market Size and Forecast, by Component
      • 16.2.10.9 Canada Market Size and Forecast, by Stage
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Application
    • 16.3.7 Europe Market Size and Forecast, by Process
    • 16.3.8 Europe Market Size and Forecast, by End User
    • 16.3.9 Europe Market Size and Forecast, by Component
    • 16.3.10 Europe Market Size and Forecast, by Stage
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.7 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Component
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Application
      • 16.3.10.6 Germany Market Size and Forecast, by Process
      • 16.3.10.7 Germany Market Size and Forecast, by End User
      • 16.3.10.8 Germany Market Size and Forecast, by Component
      • 16.3.10.9 Germany Market Size and Forecast, by Stage
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Application
      • 16.3.11.6 France Market Size and Forecast, by Process
      • 16.3.11.7 France Market Size and Forecast, by End User
      • 16.3.11.8 France Market Size and Forecast, by Component
      • 16.3.11.9 France Market Size and Forecast, by Stage
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Application
      • 16.3.12.6 Spain Market Size and Forecast, by Process
      • 16.3.12.7 Spain Market Size and Forecast, by End User
      • 16.3.12.8 Spain Market Size and Forecast, by Component
      • 16.3.12.9 Spain Market Size and Forecast, by Stage
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Application
      • 16.3.13.6 Italy Market Size and Forecast, by Process
      • 16.3.13.7 Italy Market Size and Forecast, by End User
      • 16.3.13.8 Italy Market Size and Forecast, by Component
      • 16.3.13.9 Italy Market Size and Forecast, by Stage
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Application
      • 16.3.14.6 Netherlands Market Size and Forecast, by Process
      • 16.3.14.7 Netherlands Market Size and Forecast, by End User
      • 16.3.14.8 Netherlands Market Size and Forecast, by Component
      • 16.3.14.9 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Application
      • 16.3.15.6 Sweden Market Size and Forecast, by Process
      • 16.3.15.7 Sweden Market Size and Forecast, by End User
      • 16.3.15.8 Sweden Market Size and Forecast, by Component
      • 16.3.15.9 Sweden Market Size and Forecast, by Stage
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Application
      • 16.3.16.6 Switzerland Market Size and Forecast, by Process
      • 16.3.16.7 Switzerland Market Size and Forecast, by End User
      • 16.3.16.8 Switzerland Market Size and Forecast, by Component
      • 16.3.16.9 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Application
      • 16.3.17.6 Denmark Market Size and Forecast, by Process
      • 16.3.17.7 Denmark Market Size and Forecast, by End User
      • 16.3.17.8 Denmark Market Size and Forecast, by Component
      • 16.3.17.9 Denmark Market Size and Forecast, by Stage
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Application
      • 16.3.18.6 Finland Market Size and Forecast, by Process
      • 16.3.18.7 Finland Market Size and Forecast, by End User
      • 16.3.18.8 Finland Market Size and Forecast, by Component
      • 16.3.18.9 Finland Market Size and Forecast, by Stage
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Application
      • 16.3.19.6 Russia Market Size and Forecast, by Process
      • 16.3.19.7 Russia Market Size and Forecast, by End User
      • 16.3.19.8 Russia Market Size and Forecast, by Component
      • 16.3.19.9 Russia Market Size and Forecast, by Stage
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Component
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.8 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Component
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Application
      • 16.4.9.6 China Market Size and Forecast, by Process
      • 16.4.9.7 China Market Size and Forecast, by End User
      • 16.4.9.8 China Market Size and Forecast, by Component
      • 16.4.9.9 China Market Size and Forecast, by Stage
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Application
      • 16.4.10.6 India Market Size and Forecast, by Process
      • 16.4.10.7 India Market Size and Forecast, by End User
      • 16.4.10.8 India Market Size and Forecast, by Component
      • 16.4.10.9 India Market Size and Forecast, by Stage
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Application
      • 16.4.11.6 Japan Market Size and Forecast, by Process
      • 16.4.11.7 Japan Market Size and Forecast, by End User
      • 16.4.11.8 Japan Market Size and Forecast, by Component
      • 16.4.11.9 Japan Market Size and Forecast, by Stage
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Application
      • 16.4.12.6 South Korea Market Size and Forecast, by Process
      • 16.4.12.7 South Korea Market Size and Forecast, by End User
      • 16.4.12.8 South Korea Market Size and Forecast, by Component
      • 16.4.12.9 South Korea Market Size and Forecast, by Stage
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Application
      • 16.4.13.6 Australia Market Size and Forecast, by Process
      • 16.4.13.7 Australia Market Size and Forecast, by End User
      • 16.4.13.8 Australia Market Size and Forecast, by Component
      • 16.4.13.9 Australia Market Size and Forecast, by Stage
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Application
      • 16.4.14.6 Singapore Market Size and Forecast, by Process
      • 16.4.14.7 Singapore Market Size and Forecast, by End User
      • 16.4.14.8 Singapore Market Size and Forecast, by Component
      • 16.4.14.9 Singapore Market Size and Forecast, by Stage
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Application
      • 16.4.15.6 Indonesia Market Size and Forecast, by Process
      • 16.4.15.7 Indonesia Market Size and Forecast, by End User
      • 16.4.15.8 Indonesia Market Size and Forecast, by Component
      • 16.4.15.9 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Application
      • 16.4.16.6 Taiwan Market Size and Forecast, by Process
      • 16.4.16.7 Taiwan Market Size and Forecast, by End User
      • 16.4.16.8 Taiwan Market Size and Forecast, by Component
      • 16.4.16.9 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Application
      • 16.4.17.6 Malaysia Market Size and Forecast, by Process
      • 16.4.17.7 Malaysia Market Size and Forecast, by End User
      • 16.4.17.8 Malaysia Market Size and Forecast, by Component
      • 16.4.17.9 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Application
    • 16.5.7 Latin America Market Size and Forecast, by Process
    • 16.5.8 Latin America Market Size and Forecast, by End User
    • 16.5.9 Latin America Market Size and Forecast, by Component
    • 16.5.10 Latin America Market Size and Forecast, by Stage
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Application
      • 16.5.9.6 Brazil Market Size and Forecast, by Process
      • 16.5.9.7 Brazil Market Size and Forecast, by End User
      • 16.5.9.8 Brazil Market Size and Forecast, by Component
      • 16.5.9.9 Brazil Market Size and Forecast, by Stage
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Application
      • 16.5.10.6 Mexico Market Size and Forecast, by Process
      • 16.5.10.7 Mexico Market Size and Forecast, by End User
      • 16.5.10.8 Mexico Market Size and Forecast, by Component
      • 16.5.10.9 Mexico Market Size and Forecast, by Stage
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Application
      • 16.5.11.6 Argentina Market Size and Forecast, by Process
      • 16.5.11.7 Argentina Market Size and Forecast, by End User
      • 16.5.11.8 Argentina Market Size and Forecast, by Component
      • 16.5.11.9 Argentina Market Size and Forecast, by Stage
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Component
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.8 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Component
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Component
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Application
      • 16.6.10.6 UAE Market Size and Forecast, by Process
      • 16.6.10.7 UAE Market Size and Forecast, by End User
      • 16.6.10.8 UAE Market Size and Forecast, by Component
      • 16.6.10.9 UAE Market Size and Forecast, by Stage
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Application
      • 16.6.11.6 South Africa Market Size and Forecast, by Process
      • 16.6.11.7 South Africa Market Size and Forecast, by End User
      • 16.6.11.8 South Africa Market Size and Forecast, by Component
      • 16.6.11.9 South Africa Market Size and Forecast, by Stage
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Component
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 BioNTech
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Moderna
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 CureVac
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Translate Bio
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Arcturus Therapeutics
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Sangamo Therapeutics
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 eTheRNA Immunotherapies
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Ethris
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 TriLink BioTechnologies
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Aldevron
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Ginkgo Bioworks
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Senti Biosciences
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Nutcracker Therapeutics
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 GreenLight Biosciences
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Acuitas Therapeutics
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제